LumeNXT, a privately-held company dedicated to developing surgical illumination technologies, recently appointed Marc Beer Chairman of the Board. LumeNXT’s product lines use proprietary technology to make minimally invasive operations to a preferred method of surgery. While invasive surgeries will still need to be performed under certain circumstances, doctors and surgeons would prefer to use less risky operations.
As minimally invasive procedures continue to rise, LumeNXT believes their technologies can make those surgical options for all parties involved. The team at LumeNXT consists of highly motivated, dedicated surgeons and engineers who’ve already made tremendous advancements in the field of surgical illumination. It’s important that LumeNXT develops these technologies.
A preferred method of surgeons today is using targeted illumination. This allows them to only focus on the problem areas rather than cutting too much into a patient. With the right technology, made by LumeNXT, surgeons have better visualization, precision, and flexibility; thereby, limiting risk to their patients’ health.
The advantage of LumeNXT platform is that it offers advanced illumination in a way, unlike any other brand. For a start, LumeNXT platform is used as a heat-reduction mechanism, which improves surgical precision, offers low-cost disposable options, and enhances visualization more than LumeNXT’s competition.
As for why LumeNXT wanted Marc Beer to join their company; he’s one of the most successful medical startup entrepreneurs in the industry. He founded and co-founded numerous enterprises, all of which, found success on a global scale. According to Paul Rhyne, Co-Founder of LumeNXT, Marc Beer demonstrates high levels of success that he wanted his company to experience.
Of the many successes in Marc Beer’s life, ViaCell stands out as one of the most successful. Founded in 2000, ViaCell was dedicated to collecting, preserving, and developing umbilical cord blood stem cells. Within the first seven years, the company grew into one of the robust commercialized organizations in the industry.
By 2007, ViaCell employed over 300 employees and opened on the public market as one of the desired stocks. Also in 2007, the company was acquired by PerkinElmer, but Beer didn’t leave the company. He stayed on and served as CEO while also serving as a member of the board for Erytech Pharma.
Marc Beer has 25 years of experience developing and commercializing biotechnology, pharmaceuticals, devices, and diagnostics. Rhyne hopes that Beer will bring all that experience to his new role as Chairman. With Beer leading the company as he has so many others; LumeNXT surely has a bright future. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html